Search

Welcome to the Banks Lab, Evelyn! She joined the lab as a research assistant in June, 2024.

A new paper has been published with Dr. Zsengeller as first author. The abstract and links are below: https://pubmed.ncbi.nlm.nih.gov/41020802/ Preeclampsia (PE) is a hypertensive disorder impacting 5-7% of pregnancies globally. With no causative treatment available, diagnosed patients have limited...

Dr. Heng has been selected to participate in the 2025 SGM Cancer Curriculum Advances Research Excellence (CARE) Workshop in Denver, CO. She will also present relevant basic cancer research that she is leading at the workshop.

Dr. Heng will be presenting, "Plasma miRNAs associated with cisplatin sensitivity in breast cancer." at the 2025 Harvard Institute for RNA Medicine (HiRM) seminar series on Tuesday, February 18th at 3 pm.

Mark Zeidel and Warren Hill were part of a large team led by Dr. Gary Churchill at The Jackson Laboratory in Bar Harbor Maine that just published in Nature the results of a study that followed 970 genetically diverse mice over four years. The results showed that caloric restriction and intermittent...

Dr. Secemsky kicked off 2025 with presentations at this year's THT (Boston, MA), LINC (Leipzig, Germany), and ISET (Miami, FL) vascular medicine conferences. His talks included: " Acute PE Risk Stratification: Where Do Hemodynamics Fit In?" (THT), " Bioabsorbable Scaffolds: A Revolution Below the...

A recent Aging Cell publication by Drs. Alice Rodrigues, Jan Heng, and Frank Slack identified miR-30c-5p, found in extracellular vesicles from young mice, as a promising therapeutic for reversing age-related liver fibrosis. The treatment improved insulin sensitivity and extended health span—offering...

This March, members of the Cardiovascular Imaging Section traveled to Chicago to present their research at the American College of Cardiology Conference 2025. Christy Zheng, research student, presented her work assessing technical changes to an algorithm to detect heart failure with preserved...

In a recent Nature Communications study, Dr. Annalisa Di Ruscio and team introduced aptaDiR, a novel RNA therapeutic engineered to silence DNMT1 and reverse abnormal DNA methylation in cancer. Delivered via lipid nanoparticles, aptaDiR reactivated tumor-suppressor genes and significantly reduced...

Climate and Human Health Fellowship Assistant Director, Dr. Caleb Dresser, attended the White House Climate and Health Forum, where a first-ever national heat strategy was announced.